Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma.

Saved in:
Bibliographic Details
Title: Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma.
Authors: Jeong YS; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shin JH; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kim SM; Department of Physiology, Institute of Medical Science, Jeonbuk National University Medical School, Jeonju, Jeonbuk, Korea., Sohn BH; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yim SY; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea., Kim JH; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea., Shim JJ; Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea., Lee SH; Division of Hepatobiliary and Pancreas, Department of Surgery, CHA Bundang Medical Center, CHA University, Sungnam, Korea., Chun YS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dai H; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kaseb A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kang KJ; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Korea., Eltzschig HK; Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA., MacLeod AR; Ionis Pharmaceuticals, Carlsbad, CA, USA., Luo X; Ionis Pharmaceuticals, Carlsbad, CA, USA., Revenko A; Ionis Pharmaceuticals, Carlsbad, CA, USA., Kim Y; Ionis Pharmaceuticals, Carlsbad, CA, USA., Lee JS; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Source: Cancer communications (London, England) [Cancer Commun (Lond)] 2026 Apr 08; Vol. 46, pp. 0020. Date of Electronic Publication: 2026 Apr 08 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: eCollection Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41958708
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jeong+YS%22">Jeong YS</searchLink>; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Shin+JH%22">Shin JH</searchLink>; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kim+SM%22">Kim SM</searchLink>; Department of Physiology, Institute of Medical Science, Jeonbuk National University Medical School, Jeonju, Jeonbuk, Korea.<br /><searchLink fieldCode="AU" term="%22Sohn+BH%22">Sohn BH</searchLink>; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yim+SY%22">Yim SY</searchLink>; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JH%22">Kim JH</searchLink>; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Shim+JJ%22">Shim JJ</searchLink>; Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SH%22">Lee SH</searchLink>; Division of Hepatobiliary and Pancreas, Department of Surgery, CHA Bundang Medical Center, CHA University, Sungnam, Korea.<br /><searchLink fieldCode="AU" term="%22Chun+YS%22">Chun YS</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lee+SS%22">Lee SS</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Dai+H%22">Dai H</searchLink>; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kaseb+A%22">Kaseb A</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kang+KJ%22">Kang KJ</searchLink>; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Korea.<br /><searchLink fieldCode="AU" term="%22Eltzschig+HK%22">Eltzschig HK</searchLink>; Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22MacLeod+AR%22">MacLeod AR</searchLink>; Ionis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Luo+X%22">Luo X</searchLink>; Ionis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Revenko+A%22">Revenko A</searchLink>; Ionis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Ionis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101723675%22">Cancer communications (London, England)</searchLink> [Cancer Commun (Lond)] 2026 Apr 08; Vol. 46, pp. 0020. <i>Date of Electronic Publication: </i>2026 Apr 08 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101723675 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2523-3548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225233548%22">25233548 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Commun (Lond) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41958708
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.34133/cancomm.0020
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 0020
    Titles:
      – TitleFull: Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jeong YS
      – PersonEntity:
          Name:
            NameFull: Shin JH
      – PersonEntity:
          Name:
            NameFull: Kim SM
      – PersonEntity:
          Name:
            NameFull: Sohn BH
      – PersonEntity:
          Name:
            NameFull: Yim SY
      – PersonEntity:
          Name:
            NameFull: Kim JH
      – PersonEntity:
          Name:
            NameFull: Shim JJ
      – PersonEntity:
          Name:
            NameFull: Lee SH
      – PersonEntity:
          Name:
            NameFull: Chun YS
      – PersonEntity:
          Name:
            NameFull: Lee SS
      – PersonEntity:
          Name:
            NameFull: Dai H
      – PersonEntity:
          Name:
            NameFull: Kaseb A
      – PersonEntity:
          Name:
            NameFull: Kang KJ
      – PersonEntity:
          Name:
            NameFull: Eltzschig HK
      – PersonEntity:
          Name:
            NameFull: MacLeod AR
      – PersonEntity:
          Name:
            NameFull: Luo X
      – PersonEntity:
          Name:
            NameFull: Revenko A
      – PersonEntity:
          Name:
            NameFull: Kim Y
      – PersonEntity:
          Name:
            NameFull: Lee JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 04
              Text: 2026 Apr 08
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2523-3548
          Numbering:
            – Type: volume
              Value: 46
          Titles:
            – TitleFull: Cancer communications (London, England)
              Type: main
ResultId 1